These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 4292690)

  • 1. Effects of angiotensin and renal artery constriction on erythropoietin production.
    Fisher JW; Samuels AI; Langston JW
    J Pharmacol Exp Ther; 1967 Sep; 157(3):618-25. PubMed ID: 4292690
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of vasoactive agents on erythropoietin production.
    Fisher JW; Roh BL; Malgor LA; Noveck RJ
    Isr J Med Sci; 1971; 7(7):977-85. PubMed ID: 4329106
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of indomethacin on erythropoietin production in dogs following renal artery constriction. I. The possible role of prostaglandins in the generation of erythropoietin by the kidney.
    Mujovic VM; Fisher JW
    J Pharmacol Exp Ther; 1974 Dec; 191(3):575-80. PubMed ID: 4427296
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of angiotensin, norepinephrine and renal artery constriction on erythropoietin production.
    Fisher JW; Samuels A; Langston J
    Ann N Y Acad Sci; 1968 Mar; 149(1):308-17. PubMed ID: 4297616
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of hemolysates on red cell production and erythropoietin release.
    Erslev AJ
    J Lab Clin Med; 1971 Jul; 78(1):1-7. PubMed ID: 5569248
    [No Abstract]   [Full Text] [Related]  

  • 6. Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin.
    Aiken JW; Vane JR
    J Pharmacol Exp Ther; 1973 Mar; 184(3):678-87. PubMed ID: 4347050
    [No Abstract]   [Full Text] [Related]  

  • 7. [Role of catecholamines in the cardiovascular action of angiotensin].
    Rieu M; Wassermann D; Morin JP
    J Physiol (Paris); 1970; 62 Suppl 2(2):308-9. PubMed ID: 4320777
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiotensin II natriuresis and anti-natriuresis: role of renal artery pressure in anaesthetized dogs.
    Olsen ME; Hall JE; Montaini JP; Guyton AC
    J Hypertens Suppl; 1984 Dec; 2(3):S347-50. PubMed ID: 6599679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the presence of a renin-like activity in erythropoietin preparations.
    Gould AB; Keighley G; Lowy PH
    Lab Invest; 1968 Jan; 18(1):2-7. PubMed ID: 4296171
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of angiotensin II antagonists in experimental hypertension.
    Bumpus FM; Smeby RR; Sweet C; Ferrario CM; Khosla MC
    Circ Res; 1973 May; 32():Suppl 1:150-8. PubMed ID: 4351356
    [No Abstract]   [Full Text] [Related]  

  • 11. Antagonism of angiotensin by hydralazine on renal blood flow and erythropoietin production.
    Malgor LA; Fisher JW
    Am J Physiol; 1969 Mar; 216(3):563-6. PubMed ID: 4303905
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin II sensitivity of afferent glomerular arterioles in endothelin-1 transgenic mice.
    Patzak A; Bontscho J; Lai E; Kupsch E; Skalweit A; Richter CM; Zimmermann M; Thöne-Reineke C; Joehren O; Godes M; Steege A; Hocher B
    Nephrol Dial Transplant; 2005 Dec; 20(12):2681-9. PubMed ID: 16188896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constrictor activity of angiotensins I and II on perfused vascular circuits of the dog.
    Rabito S; Binia A; Fasciolo JC
    Acta Physiol Lat Am; 1972; 22(4):246-50. PubMed ID: 4349175
    [No Abstract]   [Full Text] [Related]  

  • 14. Renin and erythropoietin in normotensive and in hypertensive patients.
    Bourgoignie JJ; Gallagher NI; Perry HM; Kurz L; Warnecke MA; Donati RM
    J Lab Clin Med; 1968 Mar; 71(3):523-36. PubMed ID: 4297147
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influence of vasomotor tonus on renal circulatory response to angiotensin].
    Astoin M
    J Physiol (Paris); 1967; 59(4 Suppl):333-4. PubMed ID: 4305999
    [No Abstract]   [Full Text] [Related]  

  • 16. Magnesium ion blockade of regional vasoconstriction.
    Levowitz BS; Goldson H; Rashkin A; Kay H; Valcin A; Mathur A; LaGuerre JN
    Ann Surg; 1970 Jul; 172(1):33-40. PubMed ID: 4316642
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal artery smooth muscle is refractory to contraction by angiotensin II.
    Whitney EG; Menice CB; Yeh J; Bagwell C; Jerius H; Brophy CM
    J Surg Res; 1996 Mar; 61(2):307-10. PubMed ID: 8656600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal production of erythropoietin in the dog.
    Abbrecht PH; Malvin RL
    Am J Physiol; 1966 Feb; 210(2):237-42. PubMed ID: 5901460
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of anti-erythropoietin-serum on erythropoietic action of growth hormone].
    Shirakura T; Yoshimatsu H; Miyao S
    Igaku To Seibutsugaku; 1972 Jan; 84(1):1-3. PubMed ID: 5064395
    [No Abstract]   [Full Text] [Related]  

  • 20. Generation of angiotensin II at peripheral vascular level: studies using angiotensin II antisera.
    Swales JD; Thurston H
    Clin Sci Mol Med; 1973 Nov; 45(5):691-700. PubMed ID: 4357224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.